Servier – Medicographia


Patient-centered approaches
in oncology: new horizons
Medicographia N°124

« Servier has put in place a diversified pipeline
of products targeting multiple and complementary
cancer hallmarks, and is continuing and
reinforcing its internal research efforts, with
a primary focus on apoptosis, as well as
developing other innovative and promising
approaches involving tumorbased mechanisms
(eg, targeted kinase inhibition) and tumor
environment (eg, immune-modulation).
Servier is also actively establishing
partnerships with academic institutions,
biotechnology companies, and pharmaceutical

Read this issue